9 More News Items for the Carcinoid and Neuroendocrine Cancer Community

Carcinoid/neuroendocrine cancer specialist Eric Liu, MD Joins Rocky Mountain Cancer CentersCarcinoid/neuroendocrine cancer specialist Dr. Eric Liu will be joining the Rocky Mountain Cancer Centers in Denver, Colorado, effective June 1, 2015. He and medical oncologist Dr. Allen Cohn, also from Rocky Mountain Cancer Centers, will head up a new Neuroendocrine Tumor Center in conjunction with HealthONE’s Presbyterian/St. Luke’s Medical Center. The Center is a wonderful new resource for the NET community! Read more here.

Breaking News: A novel treatment against neuroendocrine tumors will be the focus of a newly announced partnership between RadioMedix, a clinical phase biotechnology company focused on the development of radiopharmaceuticals for targeted diagnosis and therapy of cancer, and AREVA Med, the AREVA medical subsidiary developing innovative therapies to fight cancer. They will co-develop the next generation of PRRT agents using Alpha emitters. Read more here.

Over 50 abstracts on carcinoid and many more on neuroendocrine tumors have just been published online as part of the 2015 American Society of Clinical Oncology, ASCO, annual meeting to be held later this month in Chicago. The Annual Meeting brings together 30,000 oncology professionals from around the world. Educational sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Science sessions present the latest ground-breaking research in oral and poster format. Among carcinoid/NET specialists whose research is being presented are Dr. Matthew Kulke, Dr. Diane Reidy, Dr. Jonathan Strosberg, Dr. Aaron Vinik, and Dr. James Yao. To view the online abstracts, click here. Change the search terms to see additional abstracts, i.e. neuroendocrine tumors.

ASCO 2015 Abstracts on Carcinoid and Neuroendocrine Tumors

Save the dates for upcoming conferences for neuroendocrine cancer patients, loved ones, and medical professionals. Please check our Calendar of Events as we regularly update and add events: https://www.carcinoid.org/events.

June 20, NET Cancer Patient Conference, Minneapolis, Minnesota, sponsored by Neuroendocrine Cancer Awareness Network, click here for more information and to register.

June 27, LACNETS 2015 Patient & Caregiver Education Conference, Los Angeles, California, co-sponsored by LACNETS, the Los Angeles Carcinoid Neuroendocrine Tumor Society, and the Caring for Carcinoid Foundation. Details and an agenda coming soon!

October 3,  New Jersey Carcinoid Cancer NETwork 2015 Conference, Edison, New Jersey. Details and an agenda coming soon.

October 15-17, 8th Annual NANETS Symposium for physicians, health professionals, researchers, residents, fellows, and medical students, Austin, Texas. Click here for more information.

The Oncolytic Virus Fund at Uppsala University in Sweden, made possible with  generous support from the late Vince Hamilton as well as donations from people worldwide, will enable clinical trials to hopefully begin in autumn 2015, but the exact timing is dependent upon the Swedish Medical Product Agency’s response to the researchers’ application. Other news from Uppsala is that the virus treatment has been named AdVince after Mr. Hamilton and the virus to be used in the clinical trials has been produced and tested. “The clinical trial will start with dose escalation to ensure that the treatment is safe. Four different dosages will be tested. Three to six patients will be tested for each dosage.” Read more here

There are 2 new support groups for carcinoid/neuroendocrine cancer patients and their loved ones: N.E.T. Hopefuls in central Florida and NEPA Zebra’s in Northeast Pennsylvania. Wanda Probst heads the Florida group and Lori DeVoe is the group leader for the Pennsylvania group. Click here for a list of support groups and contact information, the list is alphabetical by state.

NEPA Zebra's carcinoid and neuroendocrine tumor support group, Pennsylvania

Congratulations to Josh Mailman upon receiving the Service Recognition Award during the 3rd Theranostics World Congress. “As a patient and patient advocate, Josh Mailman strongly encourages patients and medical practitioners to implement and practice comprehensive integrative healthcare to improve the lives of people affected by cancer. . . .” Since his diagnosis with a pancreatic neuroendocrine tumor in 2006 Josh has focused his time and energy in the nonprofit community serving as president of the Northern California CarciNET Community, as Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), on the Executive Board of the Society for Integrative Oncology (SIO), and as a member of the NCI task force for Neuroendocrine Tumors, among other activities.

3rd Theranostics World Congress, Josh Mailman, Award

The Clarence Light Orchestra & The Ten Mile Inn will present Country for a Cure featuring local musicians on June 13th in Galloway, Ohio. All proceeds will go the Neuroendocrine Cancer Research Fund at the Ohio State University James Cancer Hospital. The Dallas Moore Band will be the special guest performers. There will be food, raffles, and split the pot. Visit the Clarence Light Orchestra’s Facebook page for more information.

Country for a Cure, June 13, 2015

Print Friendly, PDF & Email